Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Elife ; 82019 04 09.
Article in English | MEDLINE | ID: mdl-30964004

ABSTRACT

HIV +Elite and Viremic controllers (EC/VCs) are able to control virus infection, perhaps because of host genetic determinants. We identified 16% (21 of 131) EC/VCs with CD4 +T cells with resistance specific to R5-tropic HIV, reversed after introduction of ccr5. R5 resistance was not observed in macrophages and depended upon the method of T cell activation. CD4 +T cells of these EC/VCs had lower ccr2 and ccr5 RNA levels, reduced CCR2 and CCR5 cell-surface expression, and decreased levels of secreted chemokines. T cells had no changes in chemokine receptor mRNA half-life but instead had lower levels of active transcription of ccr2 and ccr5, despite having more accessible chromatin by ATAC-seq. Other nearby genes were also down-regulated, over a region of ~500 kb on chromosome 3p21. This same R5 resistance phenotype was observed in family members of an index VC, also associated with ccr2/ccr5 down-regulation, suggesting that the phenotype is heritable.


Subject(s)
Disease Resistance , Down-Regulation , Family , HIV Infections/immunology , HIV Long-Term Survivors , Receptors, CCR5/biosynthesis , Adult , Aged , CD4-Positive T-Lymphocytes/chemistry , CD4-Positive T-Lymphocytes/virology , Cells, Cultured , Female , HIV-1/growth & development , Humans , Macrophages/chemistry , Macrophages/virology , Male , Middle Aged , Receptors, CCR2/biosynthesis , Viral Tropism , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...